A detailed history of Ubs Group Ag transactions in Sanofi stock. As of the latest transaction made, Ubs Group Ag holds 10,000 shares of SNY stock, worth $477,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 30,000 66.67%
Holding current value
$477,100
Previous $1.46 Million 60.41%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$48.54 - $58.53 $6.44 Million - $7.76 Million
132,628 Added 16.13%
955,111 $55.1 Million
Q2 2024

Aug 13, 2024

SELL
$45.39 - $50.36 $8.93 Million - $9.91 Million
-196,774 Reduced 19.31%
822,483 $39.9 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $3.87 Million - $4.44 Million
84,622 Added 9.05%
1,019,257 $49.5 Million
Q4 2023

Feb 09, 2024

BUY
$43.13 - $54.79 $4.48 Million - $5.69 Million
103,775 Added 12.49%
934,635 $46.5 Million
Q3 2023

Nov 09, 2023

SELL
$50.95 - $55.2 $1.01 Million - $1.09 Million
-19,730 Reduced 2.32%
830,860 $44.6 Million
Q2 2023

Aug 11, 2023

SELL
$50.45 - $57.18 $468,831 - $531,373
-9,293 Reduced 1.08%
850,590 $45.8 Million
Q1 2023

May 12, 2023

SELL
$45.86 - $54.45 $15.1 Million - $17.9 Million
-328,484 Reduced 27.64%
859,883 $46.8 Million
Q4 2022

Feb 08, 2023

SELL
$38.86 - $48.55 $2.6 Million - $3.25 Million
-66,933 Reduced 5.33%
1,188,367 $57.6 Million
Q3 2022

Nov 10, 2022

BUY
$37.22 - $100.5 $9.01 Million - $24.3 Million
241,945 Added 23.88%
1,255,300 $47.7 Million
Q2 2022

Aug 10, 2022

SELL
$48.99 - $57.46 $260,675 - $305,744
-5,321 Reduced 0.52%
1,013,355 $50.7 Million
Q1 2022

May 16, 2022

SELL
$48.48 - $53.65 $3.98 Million - $4.4 Million
-82,023 Reduced 7.45%
1,018,676 $52.3 Million
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $10.8 Million - $12 Million
229,289 Added 26.31%
1,100,699 $55.1 Million
Q3 2021

Nov 15, 2021

SELL
$47.89 - $53.12 $8.38 Million - $9.3 Million
-175,016 Reduced 16.73%
871,410 $42 Million
Q2 2021

Aug 13, 2021

BUY
$49.36 - $54.25 $10.4 Million - $11.5 Million
211,451 Added 25.32%
1,046,426 $55.1 Million
Q1 2021

May 12, 2021

SELL
$45.46 - $50.51 $366,180 - $406,858
-8,055 Reduced 0.96%
834,975 $41.3 Million
Q4 2020

Feb 11, 2021

SELL
$45.3 - $51.62 $97,983 - $111,654
-2,163 Reduced 0.26%
843,030 $41 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $4.1 Million - $4.45 Million
-82,793 Reduced 8.92%
845,193 $42.4 Million
Q2 2020

Jul 31, 2020

SELL
$42.91 - $52.5 $997,314 - $1.22 Million
-23,242 Reduced 2.44%
927,986 $47.4 Million
Q1 2020

May 01, 2020

SELL
$38.02 - $51.66 $3.29 Million - $4.46 Million
-86,402 Reduced 8.33%
951,228 $41.6 Million
Q4 2019

Feb 14, 2020

BUY
$44.25 - $50.86 $7.13 Million - $8.19 Million
161,018 Added 18.37%
1,037,630 $52.1 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $636,444 - $735,839
-15,777 Reduced 1.77%
876,612 $40.6 Million
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $1.51 Million - $1.66 Million
-37,390 Reduced 4.02%
892,389 $38.6 Million
Q1 2019

May 14, 2019

SELL
$40.83 - $45.43 $1.18 Million - $1.31 Million
-28,898 Reduced 3.01%
929,779 $41.2 Million
Q4 2018

Feb 14, 2019

BUY
$41.48 - $45.59 $1.93 Million - $2.13 Million
46,614 Added 5.11%
958,677 $41.6 Million
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $32,160 - $36,051
-804 Reduced 0.09%
912,063 $40.7 Million
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $401,135 - $439,405
-10,660 Reduced 1.15%
912,867 $36.5 Million
Q1 2018

May 15, 2018

SELL
$38.98 - $45.76 $638,804 - $749,914
-16,388 Reduced 1.74%
923,527 $37 Million
Q4 2017

Feb 14, 2018

SELL
$42.86 - $50.61 $1.24 Million - $1.46 Million
-28,901 Reduced 2.98%
939,915 $40.4 Million
Q3 2017

Nov 14, 2017

SELL
$47.04 - $50.34 $5.74 Million - $6.14 Million
-121,994 Reduced 11.18%
968,816 $48.2 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-72,860 Reduced 6.26%
1,090,810 $52.3 Million
Q1 2017

Nov 14, 2017

BUY
N/A
1,163,670
1,163,670 $52.7 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.